SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.47+0.3%Nov 28 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kramer who wrote (1065)5/7/2000 10:20:00 PM
From: scaram(o)uche  Read Replies (1) of 52153
 
The issue with Salmonella, E. coli, Listeria, etc. has always been margins. It is easy to come up with a rapid diagnostic. If you don't have reagents and associated instrumentation, you're likely to work very hard for almost nada.

Tell us about margins -- what they are and how they'll be maintained. These are not new concepts, and this is the six year chart characteristic of a company that is doing solid work on low-margin projects.......

quote.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News